Acquired von Willebrand syndrome and lymphoproliferative disorders: A case report

被引：5

作者：

Nicol, Christophe ^{[1
]}

Raj, Leela ^{[1
,2
]}

Guillerm, Gaelle ^{[1
]}

Couturaud, Francis ^{[1
,3
,4
]}

Eveillard, Jean-Richard ^{[1
]}

Pan-Petesch, Brigitte ^{[1
]}

机构：

[1] Univ Brest, CHU Brest, EA3878 GETBO, Serv Hematol,Inst Cancerohematol, Brest, France

[2] McMaster Univ, Fac Heath Sci, Hamilton, ON, Canada

[3] Univ Brest, CHU Brest, Dept Med Interne & Pneumol, EA 3878,CIC INSERM 1412, Brest, France

[4] F CRIN INNOVTE, Brest, France

来源：

CLINICAL CASE REPORTS | 2020年 / 8卷 / 05期

关键词：

acquired von Willebrand syndrome; bleeding; daratumumab; smoldering multiple myeloma; INTRAVENOUS IMMUNOGLOBULIN; MANAGEMENT; EFFICACY;

D O I：

10.1002/ccr3.2770

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acquired von Willebrand syndrome is a rare bleeding disorder often secondary to an underlying lymphoproliferative disorder. We report a case in whom response of both the acquired von Willebrand syndrome and smoldering multiple myeloma persist 14 months after daratumumab treatment discontinuation.

引用

页码：900 / 904

页数：5

共 17 条

[1] Successful management of severe refractory acquired immune bleeding disorder: Prior to insisting surgery [J].

Al-Jafar, Hassan ;

Al-Barjas, H. ;

Hashem, Raed A. ;

Refaii, Thanaa M. K. ;

AlSaeed, Ahmad M. .

INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2014, 5 (12) :1186-1189

[2] Acquired Von Willebrand syndrome and response to desmopressin [J].

Biguzzi, E. ;

Siboni, S. M. ;

Peyvandi, F. .

HAEMOPHILIA, 2018, 24 (01) :e25-e28

[3] Haemostatic management of extreme challenges to haemostasis in acquired von Willebrand syndrome [J].

Colella, M. P. ;

Duarte, G. C. ;

Marques, J. F. C., Jr. ;

De Paula, E. V. .

HAEMOPHILIA, 2012, 18 (03) :e188-e191

[4] Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature [J].

Engelen, E. T. ;

van Galen, K. P. M. ;

Schutgens, R. E. G. .

HAEMOPHILIA, 2015, 21 (04) :419-429

[5] Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome [J].

Federici, AB .

HUMAN IMMUNOLOGY, 2005, 66 (04) :422-430

[6] Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease [J].

Friederich, PW ;

Wever, PC ;

Briët, E ;

Doorenbos, CJ ;

Levi, M .

AMERICAN JOURNAL OF HEMATOLOGY, 2001, 66 (04) :292-294

[7] Long-term remission of acquired von Willebrand syndrome associated with multiple myeloma using bortezomib and dexamethasone therapy [J].

Katagiri, S. ;

Akahane, D. ;

Amano, K. ;

Ohyashiki, K. .

HAEMOPHILIA, 2016, 22 (06) :E557-E559

[8] Combined Coagulopathy Can Induce Both Hemorrhagic and Thrombotic Complications in Multiple Myeloma [J].

Kawashima, Ichiro ;

Takano, Katsuhiro ;

Kumagai, Takuma ;

Koshiishi, Megumi ;

Oishi, Saori ;

Sueki, Yuki ;

Nakajima, Kei ;

Mitsumori, Toru ;

Kirito, Keita .

INTERNAL MEDICINE, 2018, 57 (22) :3303-3306

[9] A role for intravenous immunoglobulin in the treatment of Acquired Von Willebrand Syndrome associated with IgM gammopathy [J].

Lavin, M. ;

Ryan, K. ;

White, B. ;

Byrne, M. ;

O'Connell, N. M. ;

O'Donnell, J. S. .

HAEMOPHILIA, 2018, 24 (01) :e22-e25

[10] Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy [J].

Lavin, M. ;

Brophy, T. M. ;

Rawley, O. ;

O'Sullivan, J. M. ;

Hayden, P. J. ;

Browne, P. V. ;

Ryan, K. ;

O'Connell, N. ;

O'Donnell, J. S. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (06) :1200-1205

← 1 2 →